p53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms
Related Experiment Video
Updated: Jun 16, 2026

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
Yan Wang1, Xiao-Xia Dong, Yi Cao
1Department of Pharmacology and Laboratory of Aging and Nervous Diseases (SZS0703), Soochow University School of Medicine, Suzhou, China.
Abstract:
The present study sought to investigate mechanisms by which p53 induction contributes to excitotoxic neuronal injury. Rats were intrastriatally administered the N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid (QA), the changes in the expression of p53 and its target genes involved in apoptosis and autophagy, including p53-upregulated modulator of apoptosis (PUMA), Bax, Bcl-2, damage-regulated autophagy modulator (DRAM) and other autophagic proteins including microtubule-associated protein 1 light chain 3 (LC3) and beclin 1 were assessed. The contribution of p53-mediated autophagy activation to apoptotic death of striatal neurons was assessed with co-administration of the nuclear factor-kappaB (NF-kappaB) inhibitor SN50, the p53 inhibitor Pifithrin-alpha (PFT-alpha) or the autophagy inhibitor 3-methyladenine (3-MA). The increased formation of autophagosomes and secondary lysosomes were observed with transmission electron microscope after excitotoxin exposure. QA induced increases in the expression of p53, PUMA, Bax and a decrease in Bcl-2. These changes were significantly attenuated by pre-treatment with SN50, PFT-alpha or 3-MA. SN50, PFT-alpha or 3-MA also reversed QA-induced upregulation of DRAM, the ratio of LC3-II/LC3-I and beclin 1 protein levels in the striatum. QA-induced internucleosomal DNA fragmentation and loss of striatal neurons were robustly inhibited by SN50, PFT-alpha or 3-MA. These results suggest that overstimulation of NMDA receptors can induce NF-kappaB-dependent expression of p53. p53 participates in excitotoxic neuronal death probably through both apoptotic and autophagic mechanisms.
Insights
p53 activation contributes to excitotoxic neuronal injury via apoptosis and autophagy. Inhibiting nuclear factor-kappaB (NF-kappaB) or p53 reduces neuronal death, suggesting therapeutic targets for excitotoxicity.
Area of Science:
- Neuroscience
- Molecular Biology
Background:
- Excitotoxic neuronal injury is a significant concern in neurological disorders.
- The role of p53 in neuronal death following excitotoxicity requires further elucidation.
Purpose of the Study:
- To investigate the mechanisms by which p53 induction contributes to excitotoxic neuronal injury.
- To assess the involvement of p53-mediated apoptosis and autophagy in neuronal damage.
Main Methods:
- Rats were administered quinolinic acid (QA) to induce excitotoxicity.
- Expression of p53, apoptosis-related genes (PUMA, Bax, Bcl-2), and autophagy markers (DRAM, LC3, beclin 1) were analyzed.
- Inhibitors of NF-kappaB (SN50), p53 (Pifithrin-alpha), and autophagy (3-MA) were used to assess their protective effects.
Main Results:
- QA administration increased p53, PUMA, and Bax expression while decreasing Bcl-2.
- QA exposure led to increased autophagosome and lysosome formation, upregulating DRAM, LC3-II/LC3-I ratio, and beclin 1.
- Pre-treatment with SN50, PFT-alpha, or 3-MA significantly attenuated QA-induced changes and protected against DNA fragmentation and neuronal loss.
Conclusions:
- NMDA receptor overstimulation induces NF-kappaB-dependent p53 expression.
- p53 contributes to excitotoxic neuronal death through both apoptotic and autophagic pathways.
- Targeting NF-kappaB, p53, or autophagy may offer neuroprotective strategies against excitotoxicity.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Extrinsic Apoptotic Pathway
Parkinson Disease ll: Pathophysiology
